Efficient Protocols for Fabricating a Large Human Cardiac Muscle Patch from Human Induced Pluripotent Stem Cells

Area of Science:

• Stem cell biology
• Cardiovascular research
• Regenerative medicine

Background:

• Human induced pluripotent stem cells (hiPSCs) hold promise for cardiac regenerative therapy and disease modeling.
• Efficient differentiation of hiPSCs into specific cardiac lineages is crucial for their therapeutic application.
• Current methods for cardiac cell differentiation and tissue engineering are often inefficient and time-consuming.

Purpose of the Study:

• To develop novel, efficient protocols for differentiating hiPSCs into cardiomyocytes (CMs), endothelial cells (ECs), and smooth muscle cells (SMCs).
• To create a human cardiac muscle patch (hCMP) from hiPSC-derived cells.
• To establish a method for maturing the engineered cardiac tissue and evaluate its efficacy in a large-animal model.

Main Methods:

• Developed rapid and efficient differentiation protocols for hiPSC-derived CMs, ECs, and SMCs.
• Fabricated a human cardiac muscle patch (hCMP) of clinically relevant size.
• Implemented mechanical stimulation for engineered tissue maturation.
• Evaluated the hCMP in a swine model of myocardial injury.

Main Results:

• Achieved efficient differentiation of hiPSCs into cardiac lineages within weeks.
• Successfully assembled hiPSC-derived cells into a functional hCMP.
• Demonstrated successful maturation of the engineered tissue via mechanical stimulation.
• Validated the hCMP's potential in a large-animal model of cardiac injury.

Conclusions:

• Novel protocols enable efficient generation of hiPSC-derived cardiac cells and hCMP.
• The developed hCMP is suitable for regenerative myocardial therapy.
• Engineered cardiac tissue shows promise in preclinical large-animal models.